US Stock MarketDetailed Quotes

AVNS Avanos Medical

Watchlist
  • 23.510
  • -0.400-1.67%
Close Sep 11 16:00 ET
  • 23.510
  • 0.0000.00%
Post 16:20 ET
1.08BMarket Cap138.29P/E (TTM)

Avanos Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
1.36%171.7M
4.27%166.1M
-1.58%673.3M
-4.57%173.3M
-0.58%171.3M
-0.88%169.4M
-19.30%159.3M
16.54%684.1M
407.26%181.6M
-6.41%172.3M
Operating revenue
1.36%171.7M
4.27%166.1M
-1.58%673.3M
-4.57%173.3M
-0.58%171.3M
-0.88%169.4M
-19.30%159.3M
16.54%684.1M
407.26%181.6M
-6.41%172.3M
Cost of revenue
6.28%76.1M
5.01%71.3M
1.28%293.6M
-0.51%78.3M
5.13%75.8M
3.32%71.6M
-25.22%67.9M
0.73%289.9M
2,148.57%78.7M
-23.22%72.1M
Gross profit
-2.25%95.6M
3.72%94.8M
-3.68%379.7M
-7.68%95M
-4.69%95.5M
-3.74%97.8M
-14.26%91.4M
31.75%394.2M
218.58%102.9M
11.09%100.2M
Operating expense
-10.61%89.3M
-6.87%90.8M
4.68%375.5M
-2.90%83.8M
7.89%94.3M
9.18%99.9M
-0.51%97.5M
6.06%358.7M
57.77%86.3M
0.69%87.4M
Selling and administrative expenses
-13.01%80.9M
-5.86%83.6M
2.60%335M
-5.34%74.5M
0.51%78.7M
11.78%93M
-1.44%88.8M
14.44%326.5M
30.73%78.7M
4.40%78.3M
Research and development costs
-7.35%6.3M
-6.67%7M
-6.85%27.2M
-5.56%6.8M
-14.08%6.1M
-10.53%6.8M
-3.85%7.5M
-4.58%29.2M
22.03%7.2M
-15.48%7.1M
Other operating expenses
2,000.00%2.1M
-83.33%200K
343.33%13.3M
525.00%2.5M
375.00%9.5M
-85.71%100K
1,100.00%1.2M
-86.55%3M
103.51%400K
-41.18%2M
Operating profit
400.00%6.3M
165.57%4M
-88.17%4.2M
-32.53%11.2M
-90.63%1.2M
-120.79%-2.1M
-170.93%-6.1M
191.03%35.5M
174.11%16.6M
276.47%12.8M
Net non-operating interest income expense
96.67%-100K
16.67%-2.5M
-37.50%-12.1M
0.00%-2.3M
-40.74%-3.8M
-20.00%-3M
-130.77%-3M
-183.87%-8.8M
-228.57%-2.3M
-285.71%-2.7M
Non-operating interest income
500.00%3M
20.00%600K
141.67%2.9M
42.86%1M
200.00%900K
150.00%500K
--500K
500.00%1.2M
--700K
50.00%300K
Non-operating interest expense
-11.43%3.1M
-11.43%3.1M
50.00%15M
10.00%3.3M
56.67%4.7M
29.63%3.5M
169.23%3.5M
203.03%10M
328.57%3M
233.33%3M
Other net income (expense)
Income before tax
221.57%6.2M
116.48%1.5M
-129.59%-7.9M
-37.76%8.9M
-125.74%-2.6M
-167.11%-5.1M
-224.66%-9.1M
163.42%26.7M
161.90%14.3M
274.07%10.1M
Income tax
337.50%1.9M
176.92%1M
-61.54%2M
-145.65%-2.1M
788.89%6.2M
-128.57%-800K
-168.42%-1.3M
146.43%5.2M
76.92%4.6M
-102.37%-900K
Net income
102.64%1.8M
-80.00%-900K
-222.38%-61.8M
-37.87%10.5M
-123.57%-3.7M
-644.80%-68.1M
-109.26%-500K
701.59%50.5M
46.96%16.9M
144.48%15.7M
Net income continuous Operations
200.00%4.3M
106.41%500K
-146.05%-9.9M
13.40%11M
-180.00%-8.8M
-189.58%-4.3M
-244.44%-7.8M
169.58%21.5M
137.74%9.7M
131.16%11M
Net income discontinuous operations
96.08%-2.5M
-119.18%-1.4M
-278.97%-51.9M
-106.94%-500K
8.51%5.1M
-928.57%-63.8M
--7.3M
-22.04%29M
--7.2M
--4.7M
Minority interest income
Net income attributable to the parent company
102.64%1.8M
-80.00%-900K
-222.38%-61.8M
-37.87%10.5M
-123.57%-3.7M
-644.80%-68.1M
-109.26%-500K
701.59%50.5M
46.96%16.9M
144.48%15.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
102.64%1.8M
-80.00%-900K
-222.38%-61.8M
-37.87%10.5M
-123.57%-3.7M
-644.80%-68.1M
-109.26%-500K
701.59%50.5M
46.96%16.9M
144.48%15.7M
Basic earnings per share
102.74%0.04
-100.00%-0.02
-222.22%-1.32
-36.11%0.23
-123.53%-0.08
-640.74%-1.46
-109.09%-0.01
730.77%1.08
71.43%0.36
146.58%0.34
Diluted earnings per share
102.74%0.04
-100.00%-0.02
-223.36%-1.32
-36.11%0.23
-124.24%-0.08
-661.54%-1.46
-109.09%-0.01
723.08%1.07
71.43%0.36
145.21%0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 1.36%171.7M4.27%166.1M-1.58%673.3M-4.57%173.3M-0.58%171.3M-0.88%169.4M-19.30%159.3M16.54%684.1M407.26%181.6M-6.41%172.3M
Operating revenue 1.36%171.7M4.27%166.1M-1.58%673.3M-4.57%173.3M-0.58%171.3M-0.88%169.4M-19.30%159.3M16.54%684.1M407.26%181.6M-6.41%172.3M
Cost of revenue 6.28%76.1M5.01%71.3M1.28%293.6M-0.51%78.3M5.13%75.8M3.32%71.6M-25.22%67.9M0.73%289.9M2,148.57%78.7M-23.22%72.1M
Gross profit -2.25%95.6M3.72%94.8M-3.68%379.7M-7.68%95M-4.69%95.5M-3.74%97.8M-14.26%91.4M31.75%394.2M218.58%102.9M11.09%100.2M
Operating expense -10.61%89.3M-6.87%90.8M4.68%375.5M-2.90%83.8M7.89%94.3M9.18%99.9M-0.51%97.5M6.06%358.7M57.77%86.3M0.69%87.4M
Selling and administrative expenses -13.01%80.9M-5.86%83.6M2.60%335M-5.34%74.5M0.51%78.7M11.78%93M-1.44%88.8M14.44%326.5M30.73%78.7M4.40%78.3M
Research and development costs -7.35%6.3M-6.67%7M-6.85%27.2M-5.56%6.8M-14.08%6.1M-10.53%6.8M-3.85%7.5M-4.58%29.2M22.03%7.2M-15.48%7.1M
Other operating expenses 2,000.00%2.1M-83.33%200K343.33%13.3M525.00%2.5M375.00%9.5M-85.71%100K1,100.00%1.2M-86.55%3M103.51%400K-41.18%2M
Operating profit 400.00%6.3M165.57%4M-88.17%4.2M-32.53%11.2M-90.63%1.2M-120.79%-2.1M-170.93%-6.1M191.03%35.5M174.11%16.6M276.47%12.8M
Net non-operating interest income expense 96.67%-100K16.67%-2.5M-37.50%-12.1M0.00%-2.3M-40.74%-3.8M-20.00%-3M-130.77%-3M-183.87%-8.8M-228.57%-2.3M-285.71%-2.7M
Non-operating interest income 500.00%3M20.00%600K141.67%2.9M42.86%1M200.00%900K150.00%500K--500K500.00%1.2M--700K50.00%300K
Non-operating interest expense -11.43%3.1M-11.43%3.1M50.00%15M10.00%3.3M56.67%4.7M29.63%3.5M169.23%3.5M203.03%10M328.57%3M233.33%3M
Other net income (expense)
Income before tax 221.57%6.2M116.48%1.5M-129.59%-7.9M-37.76%8.9M-125.74%-2.6M-167.11%-5.1M-224.66%-9.1M163.42%26.7M161.90%14.3M274.07%10.1M
Income tax 337.50%1.9M176.92%1M-61.54%2M-145.65%-2.1M788.89%6.2M-128.57%-800K-168.42%-1.3M146.43%5.2M76.92%4.6M-102.37%-900K
Net income 102.64%1.8M-80.00%-900K-222.38%-61.8M-37.87%10.5M-123.57%-3.7M-644.80%-68.1M-109.26%-500K701.59%50.5M46.96%16.9M144.48%15.7M
Net income continuous Operations 200.00%4.3M106.41%500K-146.05%-9.9M13.40%11M-180.00%-8.8M-189.58%-4.3M-244.44%-7.8M169.58%21.5M137.74%9.7M131.16%11M
Net income discontinuous operations 96.08%-2.5M-119.18%-1.4M-278.97%-51.9M-106.94%-500K8.51%5.1M-928.57%-63.8M--7.3M-22.04%29M--7.2M--4.7M
Minority interest income
Net income attributable to the parent company 102.64%1.8M-80.00%-900K-222.38%-61.8M-37.87%10.5M-123.57%-3.7M-644.80%-68.1M-109.26%-500K701.59%50.5M46.96%16.9M144.48%15.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 102.64%1.8M-80.00%-900K-222.38%-61.8M-37.87%10.5M-123.57%-3.7M-644.80%-68.1M-109.26%-500K701.59%50.5M46.96%16.9M144.48%15.7M
Basic earnings per share 102.74%0.04-100.00%-0.02-222.22%-1.32-36.11%0.23-123.53%-0.08-640.74%-1.46-109.09%-0.01730.77%1.0871.43%0.36146.58%0.34
Diluted earnings per share 102.74%0.04-100.00%-0.02-223.36%-1.32-36.11%0.23-124.24%-0.08-661.54%-1.46-109.09%-0.01723.08%1.0771.43%0.36145.21%0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg